Index Entries - Covid Index

1536 Results

Title	IS Publication Date
Results of a systematic review and meta‑analysis of early studies on ivermectin in SARS‑CoV‑2 infection	March 7, 2023
Results of an Open Prospective Controlled Comparative Study on the Treatment of Novel Coronavirus Infection (COVID-19): Bromhexine & Spironolactone for the Treatment of Coronavirus Infection Requiring Hospitalization	May 11, 2020
Resveratrol Inhibits HCoV-229E and SARS-CoV-2 Coronavirus Replication In Vitro	February 23, 2021
Retracted Covid-19 articles: significantly more cited than other articles within their journal of origin	April 12, 2023
Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis of Early COVID-19 and Treated at Home Within 3 Days or After 3 Days of Symptom Onset with Prescribed and Non-Prescribed Treatments Between November 2	December 30, 2021
Reverse-transcribed SARS-CoV-2 RNA can integrate into the genome of cultured human cells and can be expressed in patient-derived tissues	May 25, 2021
Reversible cerebral vasoconstriction syndrome and posterior reversible encephalopathy syndrome following vaccination: analysis of the VAERS database and systematic review	October 18, 2023
Review of COVID-19 Vaccines and the Risk of Chronic Adverse Events Including Neurological Degeneration	March 24, 2021
Review of scientific reports of harms caused by face masks, up to February 2021	February 22, 2021
Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19	April 22, 2021
Review: Calls for Market Removal of COVID-19 Vaccines Intensify: Risks Far Outweigh Theoretical Benefits	January 28, 2025
Rhabdomyolysis Secondary to COVID-19 Vaccination	May 13, 2021
Risk assessment of retinal vascular occlusion after COVID-19 vaccination	May 2, 2023
Risk for Facial Palsy after COVID-19 Vaccination, South Korea, 2021–2022	October 8, 2024
Risk of Coronavirus Disease 2019 (COVID-19) among those up-to-date and not up-to-date on COVID-19 vaccination by US CDC criteria	November 8, 2023
Risk of heavy menstrual bleeding following COVID-19 vaccination: A nationwide case-control study	September 2, 2024
Risk of Hospitalization, severe disease, and mortality due to COVID-19 and PIMS-TS in children with SARS -CoV-2 infection in Germany	November 30, 2021
Risk of myocarditis and pericarditis after a COVID-19 mRNA vaccine booster and after COVID-19 in those with and without prior SARS-CoV-2 infection: A self-controlled case series analysis in England	June 7, 2023
Risk of myocarditis and pericarditis following BNT162b2 and mRNA-1273 COVID-19 vaccination	August 19, 2022
Risk of myocarditis and pericarditis in mRNA COVID-19-vaccinated and unvaccinated populations: a systematic review and meta-analysis	June 20, 2023
Risk of rapid evolutionary escape from biomedical interventions targeting SARS-CoV-2 spike protein
Risk of SARS-CoV-2 infection and hospitalization in individuals with natural, vaccine-induced and hybrid immunity: a retrospective population-based cohort study from Estonia	November 21, 2023
Risk of severe COVID-19 infection among adults with prior exposure to children	July 27, 2022
Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study	August 26, 2021
Risk stratification for future cardiac arrest after COVID-19 vaccination	February 26, 2025
Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection	December 14, 2021
Roadmap for the Implementation of Actions by the European Commission based on the Commission Communication and the Council Recommendation on Strengthening Cooperation against Vaccine Preventable Diseases	Last update Q3 2019
Robust neutralizing antibodies to SARS-CoV-2 infection persist for months	December 4, 2020
Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19	August 14, 2020
Rochelle Walensky on the risk of COVID-19 vaccines for 12-17 year olds	June 24, 2021
Role of hydroxychloroquine in multidrug treatment of COVID-19	September 24, 2021
Role of ivermectin in the prevention of SARS-CoV-2 infection among healthcare workers in India: A matched case-control study	February 16, 2021
Rush to Use Ventilators Killed Thousands of COVID Patients	September 18, 2024
S2 subunit of SARS-nCoV-2 interacts with tumor suppressor protein p53 and BRCA: an in silico study	June 30, 2020
Sacrifice: How the Deadliest Vaccine in History Targeted the Most Vulnerable	February 18, 2025
Safe and Effective: A Second Opinion	September 28, 2022
Safe Nanoparticles: Are We There Yet?	December 31, 2020
Safety and Health Guidance: COVID-19 Infection Prevention for Logistics Employers and Employees	October 27, 2020
Safety and reactogenicity of the BNT162b2 COVID-19 vaccine: Development, post-marketing surveillance, and real-world data	February 26, 2024
Safety of COVID-19 Vaccines: Spotlight on Neurological Complications	August 29, 2022
Safety of mRNA Vaccines Administered During the First Twenty-Four Months of the International COVID-19 Vaccination Program	April 10, 2023
Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry	December 31, 2021
Safety Profiles of mRNA COVID-19 Vaccines Using World Health Organization Global Scale Database (VigiBase): A Latent Class Analysis	December 15, 2022
Safety Signals for COVID Vaccines Are Loud and Clear. Why Is Nobody Listening?	September 29, 2021
SARS-CoV-2 and the Vaccination Hype	January 17, 2022
SARS-CoV-2 antibodies persist up to 12 months after natural infection in healthy employees working in non-medical contact-intensive professions	November 24, 2022
SARS-CoV-2 antibody-positivity protects against reinfection for at least seven months with 95% efficacy	April 27, 2021
SARS-CoV-2 B.1.1.529 (Omicron) Variant — United States, December 1–8, 2021	December 17, 2021
SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19	September 8, 2020
SARS-CoV-2 elicits robust adaptive immune responses regardless of disease severity	June 4, 2021

Page 23 of 31